Viewing Study NCT01063803


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-29 @ 5:16 PM
Study NCT ID: NCT01063803
Status: COMPLETED
Last Update Posted: 2016-04-11
First Post: 2010-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
Sponsor: Ablynx, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module